| Literature DB >> 34945579 |
Hongji Ye1, Xinyi Zhang2, Yang Jiang2, Min Guo2, Xiaoming Liu2,3, Jianxin Zhao1,2,4, Hao Zhang1,2,4,5, Wei Chen1,2,4.
Abstract
Few studies have investigated the peptidomics of fermented milk by Lactobacillus delbrueckii. The aim of the present study was to interpret the peptidomic pattern of the fermented milk by five strains of L. delbrueckii ssp. bulgaricus and ssp. lactis prior to and after the simulated gastrointestinal digestion in vitro. The results indicated variations in the peptidomics among the samples, particularly between the samples of different subspecies. The peptides originating from β-casein were abundant in the samples of ssp. bulgaricus, whereas the peptides derived from αs1-casein and αs2-casein were more likely to dominate in those of ssp. lactis. For β-casein, the strains of ssp. bulgaricus displayed extensive hydrolysis in the regions of (73-97), (100-120), and (130-209), whereas ssp. lactis mainly focused on (160-209). The digestion appears to reduce the variations of the peptidomics profile in general. Among the five strains, L. delbrueckii ssp. bulgaricus DQHXNS8L6 was the most efficient in the generation of bioactive peptides prior to and after digestion. This research provided an approach for evaluating the peptide profile of the strains during fermentation and digestion.Entities:
Keywords: Lactobacillus delbrueckii; bioactive peptide; bulgaricus; comparative peptidomics; digestion; lactis
Year: 2021 PMID: 34945579 PMCID: PMC8701751 DOI: 10.3390/foods10123028
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Principal component analysis for peptidomics of skim milk and fermented milks by Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis after 12 h of fermentation at 37 °C before and after the simulated gastrointestinal digestion in vitro.
Figure 2Upset plot showing the common and differential peptides among the fermented milk samples by Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis after 12 h of fermentation at 37 °C. (a) Common and differential peptides of the samples before digestion. (b) Common and differential peptides of the samples after the simulated gastrointestinal digestion in vitro.
Figure 3Comparative peptidomic analysis between the fermented milk of Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis before and after digestion. (a) Heat map of the common peptides in the samples. (b) Peptides with top 20 variable importance in projection (VIP) scores in fermented milk of L. delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis according to partial least-squares discriminant analysis (PLS-DA). (c) Shannon index of the samples before (black) and after (grey) digestion. * and *** indicate significant difference (p < 0.05 and p < 0.001, respectively). Different lowercases letters indicate significant difference (p < 0.05) in the sample before and after digestion. (d) Peptides with top 20 VIP scores in digested samples of L. delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis according to PLS-DA. D in front of samples name mean samples after digestion.
Figure 4Heat map of αs2- and β-casein constructed from peptides identified in fermented and digested samples. Heat maps under the sequences indicated the frequency of the amino acids. A color is associated with each amino acid from white (no frequency) to black (high frequency). Heat maps under the plot indicated the hydrophilicity (red) and hydrophobicity (blue) of the corresponding sequence. (a) Heat maps constructed by peptides originated from αs2-casein in fermented and digested samples. (b) Heat maps constructed by peptides that originated from β-casein in fermented and digested samples. D in front of samples name means samples after digestion.
General peptidomic characteristics of skim milk and fermented milk samples of Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis after the simulated gastrointestinal digestion in vitro.
| Parameter | Skim Milk | DXJLHTS2M2 | DQHXNS8L6 | 2038 | D11M188 | ATCC12315 |
|---|---|---|---|---|---|---|
| Total peptides | 185 | 173 | 293 | 219 | 219 | 271 |
| Specific peptides | 83 | 24 | 77 | 34 | 29 | 87 |
| Anti-digestion peptides | 7 | 57 | 87 | 76 | 51 | 42 |
| Bioactive peptides | 16 | 22 | 37 | 26 | 35 | 28 |
| Short-sized peptides 1 | 90 | 49 | 155 | 61 | 85 | 155 |
| Medium-sized peptides 2 | 69 | 106 | 114 | 125 | 102 | 87 |
| Long-sized peptides 3 | 25 | 17 | 21 | 32 | 29 | 27 |
1 Short-sized peptides were defined as peptides with 2–5 amino acids, 2 medium-sized peptides were defined as peptides with 6–15 amino acids, 3 long-sized peptides were defined as peptides with 16–25 amino acids.
Common digestion-resistant peptides identified in fermented milk of Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis.
| Fragment | Bioactivity | Fermented Milks | D-Fermented Milks | Skim Milk | D-Skim Milk |
|---|---|---|---|---|---|
| √ | √ | √ | |||
| αs1-casein f (178–189) | √ | √ | √ | ||
|
| √ | √ | |||
| β-casein f (78–93) | √ | √ | √ | ||
|
| √ | √ | |||
|
| Antioxidant | √ | √ | ||
| β-casein f (144–154) | √ | √ | √ | ||
|
| ACE-inhibitory | √ | √ | ||
| β-casein f (192–209) | Immunomodulatory | √ | √ | √ | √ |
|
| √ | √ | |||
|
| Antioxidant | √ | √ | ||
1 The positions of fragments listed refer to search result of Maxquant, and the underline means that the fragments of peptides were not the unique in milk proteins. 2 Fragments listed with bold fonts mean that the peptides were generated during fermentation and could resist the digestion process. D in front of samples name means samples after digestion.
Bioactive peptides identified in the digested skim milk and fermented milk samples of Lactobacillus delbrueckii ssp. bulgaricus and L. delbrueckii ssp. lactis.
| Fragment | Bioactivity 2 | Skim Milk | DXJLHTS2M2 | DQHXNS8L6 | 2038 | D11M188 | ATCC12315 |
|---|---|---|---|---|---|---|---|
| 1 | √ | √ | √ | ||||
| β-lactoglobulin f (41–60) | 10 | √ | √ | ||||
| β-lactoglobulin f (102–104) | 1, 6 | √ | √ | √ | √ | √ | √ |
| β-lactoglobulin f (125–135) | 5, 8 | √ | √ | √ | |||
|
| 1, 4 | √ | √ | ||||
|
| 1 | √ | |||||
|
| 1, 3, 4, 8 | √ | √ | ||||
|
| 1 | √ | |||||
|
| 8 | √ | √ | ||||
|
| 1 | √ | √ | √ | √ | √ | √ |
| α-lactalbumin f (50–51) | 1 | √ | √ | ||||
|
| 1, 8 | √ | √ | √ | √ | √ | √ |
| αs1-casein f (23–34) | 1 | √ | √ | √ | |||
| αs1-casein f (28–34) | 1 | √ | |||||
|
| 6 | √ | |||||
| αs1-casein f (90–92) | 1, 6 | √ | |||||
|
| 1 | √ | √ | √ | √ | ||
| αs1-casein f (91–93) | 6, 12 | √ | |||||
| αs1-casein f (91–94) | 1, 6 | √ | √ | ||||
| αs1-casein f (146–149) | 6 | √ | |||||
| αs1-casein f (165–166) | 1 | √ | |||||
| αs1-casein f (176–192) | 6 | √ | √ | ||||
| αs1-casein f (180–193) | 5 | √ | √ | √ | √ | √ | √ |
| αs1-casein f (194–199) | 1, 5 | √ | |||||
| αs1-casein f (198–199) | 1 | √ | |||||
| αs2-casein f (25–32) | 1 | √ | √ | √ | |||
|
| 1 | √ | |||||
| β-casein f (59–68) | 1, 6 | √ | √ | ||||
| β-casein f (60–63) | 2, 14 | √ | |||||
| β-casein f (60–68) | 1, 6, 8 | √ | √ | ||||
| β-casein f (61–63) | 1 | √ | |||||
| β-casein f (61–68) | 1 | √ | |||||
| β-casein f (70–72) | 8 | √ | |||||
| β-casein f (73–89) | 1 | √ | √ | ||||
| β-casein f (78–91) | 6 | √ | √ | √ | |||
| β-casein f (84–86) | 1, 4, 6, 9, 13, 15, 16 | √ | √ | ||||
| β-casein f (106–113) | 5 | √ | √ | √ | |||
| β-casein f (130–140) | 1 | √ | √ | √ | √ | ||
| β-casein f (132–140) | 1 | √ | √ | √ | |||
| β-casein f (135–137) | 8 | √ | √ | √ | √ | ||
| β-casein f (142–154) | 6 | √ | √ | √ | √ | √ | |
| β-casein f (143–154) | 1, 4 | √ | √ | √ | √ | √ | |
| β-casein f (145–154) | 1 | √ | √ | √ | √ | √ | |
| β-casein f (145–160) | 1, 4 | √ | √ | √ | |||
| β-casein f (151–153) | 1 | √ | |||||
| β-casein f (169–176) | 6 | √ | |||||
| β-casein f (191–193) | 4, 6, 11 | √ | √ | √ | |||
| β-casein f (191–202) | 1 | √ | √ | √ | √ | √ | √ |
| β-casein f (191–209) | 1 | √ | |||||
| β-casein f (192–202) | 1, 4 | √ | √ | √ | √ | √ | √ |
| β-casein f (192–209) | 11 | √ | √ | √ | √ | √ | √ |
| β-casein f (193–202) | 1, 4, 6, 7, 11 | √ | √ | √ | √ | √ | |
| β-casein f (193–209) | 1, 5, 7, 11 | √ | √ | √ | √ | √ | √ |
|
| 1 | √ | |||||
| κ-casein f (14–17) | 1 | √ | √ | √ | |||
| κ-casein f (30–32) | 5, 6 | √ | √ | √ | |||
| κ-casein f (58–60) | 8 | √ | |||||
| κ-casein f (96–106) | 6 | √ | √ | √ | √ | √ | |
| κ-casein f (97–106) | 6 | √ | √ | √ | √ | ||
| κ-casein f (150–151) 3 | 1 | √ |
1 The positions of fragments listed referred to MDPDB, and the underline means that the fragments of peptides were not unique in milk protein. 2 Bioactivity represented by numbers is as follows: 1, ACE-inhibitory; 2, Anticancer; 3, Antihypertensive; 4, Anti-inflammatory; 5, Antimicrobial; 6, Antioxidant; 7, Antithrombotic; 8, DPP-IV inhibitory; 9, Enhance insulin signaling; 10, Hypocholesterolemic; 11, Immunomodulatory; 12, Improves cognitive decline; 13, Nitric oxide liberation; 14, Opioid; 15, Reduces bone loss; 16, Stimulates trabecular bone growth. 3 The derived protein was κ-casein Genetic Variant F1.